Skip to Content

AMR Industry Alliance Produces First Report

On January 18th, The AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR).

AMR Industry Alliance Produces First Report

On January 18th, The AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR).

The Alliance brings together over 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations from 20 countries.

The data and case studies collected in the Alliance report provide unique insights into the practical steps members are taking to respond to AMR in the areas of research and science, access, appropriate use, and the environment.

The Test Target Treat™ initiative is featured as a case study on the commitment by industry to promote appropriate use of antimicrobials.

AMR has the potential to turn back the clock on modern medicine. In response to this public health threat and its social and economic consequences, the United Nations in 2016 called for concerted action from governments and various sectors to address the implications of AMR. The AMR Industry Alliance is the life sciences industry’s response to this call for action.

“This first report is ground-breaking for several reasons,” explains Thomas Cueni, chair of the Alliance. “It is unique in that the companies have committed to walk the talk together and report on their progress. It is the first industry-wide grouping of this scale that has been set up to respond to the AMR emergency.”

The report measure progress in four areas:

  • Research and science
  • Access
  • Appropriate use
  • Manufacturing and the environment

The full Progress report can be found Here

The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Alere or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Alere or TestTargetTreat.com. Neither Alere nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.

Explore Related Content and Videos

News

Free Online Course on Antimicrobial Stewardship – Register Now!

Read more

News

New Respiratory Infections Team Utilzes Rapid Tests to Reduce Both Hospital Stay for Patients with Pneumonia and Unnecessary Antibiotic Use

Read more

Current Approaches to Accurate C. difficile Diagnosis

Current Approaches to Accurate C. difficile Diagnosis

Read the Monograph